Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
209 EUR | -0.33% | -3.29% | -10.99% |
06-13 | REGENXBIO Inc. Announces Chief Executive Officer Changes | CI |
06-12 | Biogen executive plays down looming competition for its Alzheimer's drug | RE |
Sales 2024 * | 9.52B 8.9B 13.04B | Sales 2025 * | 9.56B 8.94B 13.09B | Capitalization | 32.61B 30.51B 44.66B |
---|---|---|---|---|---|
Net income 2024 * | 1.94B 1.82B 2.66B | Net income 2025 * | 2.26B 2.11B 3.09B | EV / Sales 2024 * | 3.74 x |
Net Debt 2024 * | 2.99B 2.8B 4.1B | Net Debt 2025 * | 614M 574M 840M | EV / Sales 2025 * | 3.48 x |
P/E ratio 2024 * |
17.3
x | P/E ratio 2025 * |
14.9
x | Employees | 7,570 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.81% |
Latest transcript on Biogen Inc.
1 day | -0.33% | ||
1 week | -3.29% | ||
Current month | +1.01% | ||
1 month | -0.05% | ||
3 months | +3.57% | ||
6 months | -9.13% | ||
Current year | -10.99% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 22-11-13 | |
Director of Finance/CFO | 60 | 20-08-14 | |
Nicole Murphy
COO | Chief Operating Officer | - | 14-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 09-12-31 |
William Hawkins
BRD | Director/Board Member | 70 | 19-06-18 |
Caroline Dorsa
CHM | Chairman | 64 | 10-01-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-21 | 209 | -0.33% | 159 |
24-06-20 | 209.7 | +1.50% | 396 |
24-06-19 | 206.6 | -2.36% | 390 |
24-06-18 | 211.6 | 0.00% | 4 |
24-06-17 | 211.6 | -2.08% | 9,757 |
Delayed Quote Xetra, June 21, 2024 at 11:35 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.22% | 93.91B | |
-1.32% | 38.4B | |
+76.30% | 28.2B | |
-13.11% | 15.91B | |
+0.68% | 14.22B | |
-12.06% | 11.54B | |
+185.28% | 10.74B | |
-53.00% | 9.47B | |
+3.52% | 8.91B |
- Stock Market
- Equities
- BIIB Stock
- IDP Stock